Q-omics provides the consensus-scored FAM169B profile across patient tissues and cancer cell-line models. Additionally, FAM169B RNA expression shows 4,587 significant protein co-abundance associations, with the highest sampling consensus in PDAC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for FAM169B — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with FAM169B in patient tissues and cancer cell lines. In patient samples, FAM169B shows the broadest associations at the RNA and protein expression levels, with PDAC recurring as the lineage with the largest associated feature set. In cancer cell lines, FAM169B RNA and mutation anchors are most strongly linked to RNA-expression features, especially in PANCREAS, while CRISPR and shRNA rows add functional-dependency signals in LIVER and SKIN.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	4,587	PDAC (1312)	view →
Function (mass-spec)	391	GBM (97)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼CRISPR
CRISPR	1,865	PANCREAS (188)	view →
RNA	1,244	LIVER (304)	view →
▼shRNA
shRNA	1,526	SKIN (391)	view →
CRISPR	1,329	CNS (199)	view →